rs104894732

Variant summary

Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP5

The NM_003332.4(TYROBP):​c.2T>C​(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,592 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).

Frequency

Genomes: not found (cov: 31)
Exomes š‘“: 6.8e-7 ( 0 hom. )

Consequence

TYROBP
NM_003332.4 start_lost

Scores

6
7
3

Clinical Significance

Pathogenic no assertion criteria provided P:1O:1

Conservation

PhyloP100: 3.00
Variant links:
Genes affected
TYROBP (HGNC:12449): (transmembrane immune signaling adaptor TYROBP) This gene encodes a transmembrane signaling polypeptide which contains an immunoreceptor tyrosine-based activation motif (ITAM) in its cytoplasmic domain. The encoded protein may associate with the killer-cell inhibitory receptor (KIR) family of membrane glycoproteins and may act as an activating signal transduction element. This protein may bind zeta-chain (TCR) associated protein kinase 70kDa (ZAP-70) and spleen tyrosine kinase (SYK) and play a role in signal transduction, bone modeling, brain myelination, and inflammation. Mutations within this gene have been associated with polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), also known as Nasu-Hakola disease. Its putative receptor, triggering receptor expressed on myeloid cells 2 (TREM2), also causes PLOSL. Multiple alternative transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Mar 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 5 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 1 pathogenic variants. Next in-frame start position is after 48 codons. Genomic position: 35907533. Lost 0.415 part of the original CDS.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-35908227-A-G is Pathogenic according to our data. Variant chr19-35908227-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 5797.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr19-35908227-A-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TYROBPNM_003332.4 linkc.2T>C p.Met1? start_lost Exon 1 of 5 ENST00000262629.9 NP_003323.1 O43914-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TYROBPENST00000262629.9 linkc.2T>C p.Met1? start_lost Exon 1 of 5 1 NM_003332.4 ENSP00000262629.3 O43914-1

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461592
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
727102
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 Pathogenic:1Other:1
Oct 08, 2002
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

-
GeneReviews
Significance: not provided
Review Status: no classification provided
Collection Method: literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.60
D
BayesDel_noAF
Pathogenic
0.34
CADD
Uncertain
24
DANN
Uncertain
0.98
DEOGEN2
Benign
0.018
T;.;.;T;.
Eigen
Uncertain
0.27
Eigen_PC
Uncertain
0.30
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Uncertain
0.90
D;D;D;D;D
M_CAP
Pathogenic
0.88
D
MetaRNN
Pathogenic
0.99
D;D;D;D;D
MetaSVM
Uncertain
-0.16
T
PROVEAN
Benign
-1.2
N;.;N;N;.
REVEL
Uncertain
0.50
Sift
Pathogenic
0.0
D;.;D;D;.
Sift4G
Pathogenic
0.0
D;D;D;D;D
Polyphen
0.86, 0.73
.;.;.;P;P
Vest4
0.93
MutPred
0.91
Gain of glycosylation at M1 (P = 0.0331);Gain of glycosylation at M1 (P = 0.0331);Gain of glycosylation at M1 (P = 0.0331);Gain of glycosylation at M1 (P = 0.0331);Gain of glycosylation at M1 (P = 0.0331);
MVP
0.97
ClinPred
1.0
D
GERP RS
4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.95
gMVP
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs104894732; hg19: chr19-36399129; API